BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17349013)

  • 61. Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients.
    Adu-Gyamfi CG; Snyman T; Hoffmann CJ; Martinson NA; Chaisson RE; George JA; Suchard MS
    Clin Infect Dis; 2017 Oct; 65(8):1356-1358. PubMed ID: 29017244
    [TBL] [Abstract][Full Text] [Related]  

  • 62. C-reactive protein in relation to early atherosclerosis and periodontitis.
    Yakob M; Meurman JH; Jogestrand T; Nowak J; Söder PÖ; Söder B
    Clin Oral Investig; 2012 Feb; 16(1):259-65. PubMed ID: 21136129
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum uric acid: marker for atherosclerosis as it is positively associated with "atherogenic index of plasma".
    Baliarsingh S; Sharma N; Mukherjee R
    Arch Physiol Biochem; 2013 Feb; 119(1):27-31. PubMed ID: 23083415
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Indoleamine 2,3-dioxygenase activity as a potential biomarker of immune suppression during visceral leishmaniasis.
    Gangneux JP; Poinsignon Y; Donaghy L; Amiot L; Tarte K; Mary C; Robert-Gangneux F
    Innate Immun; 2013 Dec; 19(6):564-8. PubMed ID: 23413147
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased Activity of the Immunoregulatory Enzyme Indoleamine-2,3-Dioxygenase with Consecutive Tryptophan Depletion Predicts Death in Patients with Neuroendocrine Neoplasia.
    Pschowski R; Pape UF; Fusch G; Fischer C; Jann H; Baur A; Arsenic R; Wiedenmann B; von Haehling S; Pavel M; Schefold JC
    Neuroendocrinology; 2017; 104(2):135-144. PubMed ID: 26954941
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development.
    Cole JE; Astola N; Cribbs AP; Goddard ME; Park I; Green P; Davies AH; Williams RO; Feldmann M; Monaco C
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13033-8. PubMed ID: 26438837
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tryptophan Metabolism in Atherosclerosis and Diabetes.
    Sudar-Milovanovic E; Gluvic Z; Obradovic M; Zaric B; Isenovic ER
    Curr Med Chem; 2022; 29(1):99-113. PubMed ID: 34269660
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The immunometabolic role of indoleamine 2,3-dioxygenase in atherosclerotic cardiovascular disease: immune homeostatic mechanisms in the artery wall.
    Ketelhuth DFJ
    Cardiovasc Res; 2019 Jul; 115(9):1408-1415. PubMed ID: 30847484
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Summaries for patients. Can special cholesterol tests help predict a person's risk for atherosclerosis?
    Ann Intern Med; 2005 May; 142(9):I38. PubMed ID: 15867400
    [No Abstract]   [Full Text] [Related]  

  • 70. [Indoleamine 2, 3-dioxygenase activity for breast cancer patients with recurrence 5 or more years after surgery].
    Sakurai K; Fujisaki S; Nagashima S; Maeda T; Tomita R; Suzuki S; Hara Y; Enomoto K; Amano S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1590-2. PubMed ID: 24393858
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elevated indoleamine-2,3-dioxygenase enzyme activity in a novel mouse model of HIV-associated atherosclerosis.
    Kearns AC; Velasquez S; Liu F; Dai S; Chen Y; Lehmicke G; Gordon J; Rappaport J; Qin X
    AIDS; 2019 Aug; 33(10):1557-1564. PubMed ID: 31306164
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Th17/Treg balance and indoleamine 2,3 dioxygenase activity in periodontitis-associated atherosclerotic patients.
    Yang J; Hao T; Liu Y; Huang J; Wu W; Wu J; Sun W
    J Int Med Res; 2022 Feb; 50(2):3000605221080877. PubMed ID: 35220782
    [TBL] [Abstract][Full Text] [Related]  

  • 73. White blood cell count and cardiovascular biomarkers of atherosclerosis.
    Sekitani Y; Hayashida N; Kadota K; Yamasaki H; Abiru N; Nakazato M; Maeda T; Ozono Y; Takamura N
    Biomarkers; 2010 Aug; 15(5):454-60. PubMed ID: 20507253
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical Evaluation of Indoleamine 2, 3-Dioxygenase in the Serum of Patients with Locally Advanced Breast Cancer during Mohs Paste Treatment].
    Kubota H; Sakurai K; Fujisaki S; Hara Y; Suzuki S; Adachi K; Tomita R; Enomoto K; Hirano T; Saga R; Makishima M
    Gan To Kagaku Ryoho; 2017 Oct; 44(10):915-917. PubMed ID: 29066694
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Is the variant c.422+90G → A in intron 4 of indoleamine 2, 3 -dioxygenase (IDO) gene related to age related cataracts?
    Mamata M; Sridhar G; Reddy KR; Nagaraju T; Padma T
    Mol Vis; 2011; 17():1203-8. PubMed ID: 21617756
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasma and Urine Indoleamine 2,3-Dioxygenase Activity: Promising Biomarkers for Chronic Kidney Disease and Inflammation Status.
    Hong H; Zhou S; Shi H; Li M
    J Inflamm Res; 2022; 15():5129-5139. PubMed ID: 36105386
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Editorial comment.
    Hegele RA
    Curr Opin Lipidol; 2013 Apr; 24(2):109-10. PubMed ID: 23481228
    [No Abstract]   [Full Text] [Related]  

  • 78. Low indoleamine 2, 3 dioxygenase (IDO) activity is associated with psycho-obstetric risk.
    Gumusoglu S; Meincke CR; Kiel M; Betz A; Nuckols V; DuBose L; Steidele J; Sweezer E; Santillan D; Stroud AK; Pierce GL; Santillan MK
    Pregnancy Hypertens; 2024 Mar; 35():12-18. PubMed ID: 38064980
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes.
    Zaric BL; Radovanovic JN; Gluvic Z; Stewart AJ; Essack M; Motwalli O; Gojobori T; Isenovic ER
    Front Immunol; 2020; 11():551758. PubMed ID: 33117340
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relation of kynurenine/tryptophan with immune and inflammatory markers in coronary artery disease.
    Ozkan Y; Sukuroglu MK; Tulmac M; Kisa U; Simsek B
    Clin Lab; 2014; 60(3):391-6. PubMed ID: 24697114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.